Kymera Therapeutics Inc
Kymera Therapeutics Inc (KYMR) Wheel Strategy
KYMR wheel strategy scan found 89 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 95.2%.
Read more
Running a KYMR wheel strategy lets you generate consistent premium income on Kymera Therapeutics Inc while setting your own entry and exit prices on the underlying. Kymera Therapeutics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own KYMR, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best KYMR wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on KYMR, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable KYMR wheel from a losing one.
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors.
The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the KYMR wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your KYMR wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Dec 18, 2026 | 105.00 | $20.70 | $23.00 | -0.33 | 84 | 23% | 55.5% | 95.2% | 39 |
| Dec 18, 2026 | 100.00 | $18.40 | $20.55 | -0.30 | 84 | 23% | 62.5% | 89.3% | 512 |
| Dec 18, 2026 | 95.00 | $16.00 | $18.15 | -0.28 | 84 | 23% | 69.5% | 83.0% | 44 |
| Jan 15, 2027 | 105.00 | $23.00 | $24.90 | -0.32 | 112 | 23% | 53.6% | 77.3% | 2 |
| Dec 18, 2026 | 90.00 | $14.00 | $15.95 | -0.25 | 84 | 23% | 76.1% | 77.0% | 504 |
| Jan 15, 2027 | 100.00 | $20.50 | $22.40 | -0.30 | 112 | 23% | 59.8% | 73.0% | 9 |
| Dec 18, 2026 | 85.00 | $12.00 | $14.15 | -0.22 | 84 | 23% | 82.2% | 72.3% | 25 |
| Jan 15, 2027 | 95.00 | $18.00 | $20.10 | -0.27 | 112 | 23% | 66.0% | 69.0% | 1 |
| Dec 18, 2026 | 80.00 | $10.50 | $12.25 | -0.20 | 84 | 23% | 87.4% | 66.5% | 1 |
| Jan 15, 2027 | 90.00 | $15.50 | $17.65 | -0.25 | 112 | 23% | 72.1% | 63.9% | 1 |
As of September 25, 2026
Run the Wheel on KYMR With Confidence
Find the best KYMR wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→